PharmAthene, Inc. (NYSEMKT:PIP) plummeted -69.39 percent and ended the day at $1.01. The Average Volume of the company is 1.8 Million and P/E (price to earnings) ratio is 0.58, while Forward P/E ratio is 0.

Aegis Capital Initiated its coverage for PharmAthene, Inc. (NYSEMKT:PIP) in a note sent to investors on 6-Mar-13. The research firm Initiated the stock to Buy. Moreover, Rodman & Renshaw issued Upgrade rating for the stock on 4-Jun-12. WBB Securities also Downgrade the company to Hold on 28-Nov-11, 2016. Additionally, Rodman & Renshaw Downgrade its ratings on the stock to Mkt Underperform.

The highest price PIP stock touched in the last 12 month was $3.5 and the lowest price it hit in the same period was $0.47. The stock has a Return on Assets of 221.8 percent, Return on Investment of -20.9 percent and a Return on Equity of 238.1 percent. The company’s market cap is $64.01 Million.

Price Target is an important factor while doing analysis of a stock. According to 1 analysts, Price Target for PharmAthene, Inc. (NYSEMKT:PIP) may hit a high of $6. The average and low price target for the stock are $6 and $6, respectively.

Now we look at the Moving Averages, the 200-day is -63.02, the 50-day is -68.75 and the 20-day is -69.23. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

PharmAthene, Inc. (NYSEMKT:PIP) performance during the last one year Degraded -41.62 percent, while its year to date (YTD) performance showed a Negative trend of -68.92 percent. The stock Fell -60.24 percent over the past six months. The stock’s quarterly performance indicates a Negative momentum of -63.27 percent, whereas its last one month trend is Pessimistic with -69.39 percent. Its weekly performance showed a downward trend of -68.44 percent.

Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 0 percent, operating profit margin was 0 percent, whereas gross profit margin stands at 0 percent. Beta factor was calculated at 2.4.

PharmAthene, Inc. (NYSEMKT:PIP) has 63.7 Million shares outstanding and 62.81 Million shares were floated in market. The short ratio in the company’s stock is documented at 0.37 and the short float is around of 1.05%. The stock’s average true range of stands at 0.3, while the relative strength index is 12.57.

Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 37, current ratio was 37, LT Debt/Equity ratio was 0 and Total Debt/Equity ratio was 0.